The global immunohistochemistry (IHC) market was valued at USD 2.33 billion in 2022 and is projected to experience a compound annual growth rate (CAGR) of 5.8% from 2023 to 2030. This growth is largely driven by the increasing adoption of automation and machine learning technologies in immunohistochemistry, alongside the launch of advanced technological solutions in the field. The evolution of IHC protocols has led to heightened demand for these techniques in disease diagnosis. Furthermore, the rise in product approvals and the introduction of innovative IHC systems designed for diagnosing diseases are also fueling market expansion.

For example, in August 2021, the FDA granted approval for Roche’s VENTANA MMR RxDx Panel, which is intended to identify dMMR solid tumor patients who are eligible for anti-PD-1 immunotherapy. Companies are actively launching new products to enhance their market presence, contributing to revenue growth. A case in point is Roche’s introduction of the DISCOVERY Green HRP kit in March 2021, which facilitates the detection and profiling of biomarkers and cell populations in tissue-based research. This kit can be used in conjunction with other detection kits, thereby increasing the multiplexing capacity for both in situ hybridization and immunohistochemistry. Additionally, in March 2023, Paige integrated AI algorithms from Mindpeak into its platform for quantifying IHC biomarkers. Mindpeak specializes in image analysis software and has developed AI algorithms specifically for analyzing IHC slides of lung and breast tissue, which are now accessible on the Paige platform. However, traditional IHC technology is typically restricted to single parametric evaluations of samples.

Gather more insights about the market drivers, restrains and growth of the Immunohistochemistry Market

Product Insights

Delving into product segmentation, the antibodies segment emerged as the market leader in 2022, accounting for a substantial 40.96% share of the overall market. This dominance can be attributed to the critical role that antibodies play in disease diagnosis and drug testing. Monoclonal antibodies, along with various antibody-related products such as Fc-fusion proteins, antibody fragments, and antibody-drug conjugates, have established themselves as the predominant product class in terms of usage rates. The versatility of antibodies allows them to be utilized across a wide array of applications, including but not limited to pathology, neuropathology, and hematopathology. This broad applicability reinforces their significance in both clinical and research settings.

Looking ahead, kits are projected to expand at the fastest CAGR throughout the forecast period. The increasing preference for kits is largely due to their ability to streamline the IHC procedure. By eliminating the need for meticulous selection of appropriate combinations of antibodies and stains for specific tissue samples, kits significantly reduce the time and effort required for the IHC process. The compact nature and ease of use associated with these products are expected to drive their adoption further.

IHC kits are especially valuable in academic institutions and research laboratories, where researchers often require these products in smaller quantities for conducting specialized studies. As research initiatives continue to grow and evolve, there is a corresponding increase in the use of IHC assays, contributing to the overall growth of the kits segment. This trend is particularly relevant as more institutions recognize the importance of IHC in developing targeted therapies and conducting advanced research in various medical fields.

In summary, the global immunohistochemistry market is poised for significant growth driven by advancements in technology, increased demand for accurate diagnostic tools, and the expanding range of applications for IHC products. The ongoing development of innovative solutions, along with the strategic launch of new products by key players, will likely continue to shape the market landscape, presenting ample opportunities for growth and expansion in the coming years. As the field of immunohistochemistry continues to evolve, it will undoubtedly play an increasingly vital role in the diagnosis and treatment of various diseases, particularly in oncology and personalized medicine.

Order a free sample PDF of the Immunohistochemistry Market Intelligence Study, published by Grand View Research.